A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients

BACKGROUND: Iron deficiency anaemia is common in patients with chronic kidney disease, and intravenous iron is the preferred treatment for those on haemodialysis. The aim of this trial was to compare the efficacy and safety of iron isomaltoside 1000 (Monofer®) with iron sucrose (Venofer®) in haemodi...

תיאור מלא

מידע ביבליוגרפי
Autores principales: Bhandari, Sunil, Kalra, Philip A., Kothari, Jatin, Ambühl, Patrice M., Christensen, Jeppe H., Essaian, Ashot M., Thomsen, Lars L., Macdougall, Iain C., Coyne, Daniel W.
פורמט: Online Artículo Texto
שפה:English
יצא לאור: Oxford University Press 2015
נושאים:
Clinical Science
גישה מקוונת:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550440/
https://www.ncbi.nlm.nih.gov/pubmed/25925701
http://dx.doi.org/10.1093/ndt/gfv096

אינטרנט

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550440/
https://www.ncbi.nlm.nih.gov/pubmed/25925701
http://dx.doi.org/10.1093/ndt/gfv096

פריטים דומים